| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135653 Antibodies Against HER2 Truncated Variant CTF-611 |
| 06/09/2011 | US20110135648 Anti-neublastin antibodies and uses thereof |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135645 Human antibodies neutralizing human metapneumovirus |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135640 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135633 Chronic lymphocytic leukemia cell line |
| 06/09/2011 | US20110135629 EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use |
| 06/09/2011 | US20110135612 Compositions to effect neuronal growth |
| 06/09/2011 | US20110135606 Test systems for the analysis of polypeptides and cells adhering to silicones |
| 06/09/2011 | US20110135605 Methods and products related to treatment and prevention of hepatitis c virus infection |
| 06/09/2011 | US20110135578 Mycobacterial infections |
| 06/09/2011 | US20110135575 Metalloprotein mri contrast agents and related methods |
| 06/09/2011 | US20110135574 Methods of treating kidney disease |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | US20110135540 Apparatus and method for specimen suitability testing |
| 06/09/2011 | US20110135539 Microchip and Process for Producing Microchip |
| 06/09/2011 | US20110135538 Microchip |
| 06/09/2011 | US20110133762 Cartridge device for blood analysis |
| 06/09/2011 | US20110133103 Indicator devices and articles comprising the indicator device |
| 06/09/2011 | US20110132778 Test element coding apparatuses, systems and methods |
| 06/09/2011 | US20110132777 Method of measuring quantity of substrate |
| 06/09/2011 | US20110132776 Method of measuring quantity of substrate |
| 06/09/2011 | US20110132759 Biosensors and Methods of Making |
| 06/09/2011 | US20110132523 Surrogate patch for composite repair process |
| 06/09/2011 | DE202010016518U1 Elektrochemischer Biosensorteststreifen zur Identifizierung einer Entsprechenden Biosensorvorrichtung Electrochemical Biosensorteststreifen for identifying a corresponding one biosensor |
| 06/09/2011 | DE202010016517U1 System zur Messung der Analytkonzentration mit Störsubstanzen-Korrektur System for measuring the analyte concentration with interfering substances correction |
| 06/09/2011 | DE112009001301T5 Mittel und Verfahren zur Beurteilung einer erhöhten Peroxisomenproliferation Means and methods for assessment of increased peroxisome proliferation |
| 06/09/2011 | DE112009000338T5 Verbesserte Verfahren für eine Gas- und/oder Dampfphasenanalyse biologischer Assays Improved method for a gas and / or vapor phase analysis of biological assays |
| 06/09/2011 | DE102010021281A1 Detektion von Kraftstoffalkoholgehalt mittels eines Abgassensors Detection of fuel alcohol content by means of an exhaust gas sensor |
| 06/09/2011 | DE102009057050A1 Urine-indicator-unit for use in toilets for detecting fresh and dried urine, has indicator for colored detection of fresh and dried urine and its contents |
| 06/09/2011 | DE102009056863A1 Device for measuring hydrogen concentration in gas mixture in exhaust gas pipeline of fuel cell system of vehicle, has thermal insulation arranged between pipeline element of fuel cell system and heating element |
| 06/09/2011 | DE102009056856A1 Hydrogen concentration detecting device for use in hydrogen-containing gas mixture in fuel cell system i.e. polymer electrolyte membrane fuel cell system, of vehicle, has sensor enclosed with isolated material opposite to environment |
| 06/09/2011 | DE102009056849A1 Method for determining value of biological oxygen demand in five days, involves determining concentrations for two groups with organic samples in analysis process, and evaluating concentrations to determine biological oxygen demand-values |
| 06/09/2011 | DE102007005472B4 Verfahren und Vorrichtung zum Herstellen eines molekularen Films mit einer eingestellten Dichte Method and apparatus for producing a molecular film having an adjusted density |
| 06/09/2011 | CA2818133A1 Biological pathways associated with chemotherapy treatment in breast cancer |
| 06/09/2011 | CA2784434A1 Assay for diagnosis of cardiac myocyte damage |
| 06/09/2011 | CA2782803A1 Biomarkers for determining an allograft tolerant phenotype |
| 06/09/2011 | CA2782770A1 Methods for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation |
| 06/09/2011 | CA2782559A1 Gas sensor with compensation for baseline variations |
| 06/09/2011 | CA2782547A1 Method for incorporating internal polar and ionizable groups in proteins |
| 06/09/2011 | CA2782544A1 Biochemical serum marker |
| 06/09/2011 | CA2782465A1 Combined on-lattice/off-lattice optimization method for rigid body docking |
| 06/09/2011 | CA2782459A1 Arf6 as a new target for treating alzheimer's disease |
| 06/09/2011 | CA2782432A1 Diagnostic method for alzheimer's disease |
| 06/09/2011 | CA2782429A1 Assay method and apparatus |
| 06/09/2011 | CA2782415A1 Means and methods for diagnosing multiple sclerosis |
| 06/09/2011 | CA2782330A1 Improved methods and compositions for detecting and treating cea-expressing cancers |
| 06/09/2011 | CA2782299A1 Methods for treating cancers comprising k-ras mutations |
| 06/09/2011 | CA2782269A1 Enzymatic activity based-detection |
| 06/09/2011 | CA2782090A1 Improved method for screening a potential modulator compound of a taste receptor |
| 06/09/2011 | CA2781875A1 Peptide reagents and method for inhibiting autoantibody antigen binding |
| 06/09/2011 | CA2780751A1 Multiplanar lateral flow assay with sample compressor |
| 06/09/2011 | CA2778675A1 Combination therapy for treating cancer and diagnostic assays for use therein |
| 06/09/2011 | CA2772285A1 Biomarkers for predicting sustained response to hcv treatment |
| 06/08/2011 | EP2330424A1 COPD diagnosis |
| 06/08/2011 | EP2330423A1 Means and method for diagnosing diabetes |
| 06/08/2011 | EP2330422A1 Use of secreted phospholipases A2 in the diagnosis and treatment of malaria |
| 06/08/2011 | EP2330421A1 Immunochromatography method |
| 06/08/2011 | EP2330420A1 Diagnosis method and diagnosis kit for dermatomyositis |
| 06/08/2011 | EP2330418A1 Methods of quantitative determination of neurogenesis in vivo |
| 06/08/2011 | EP2330417A2 System and method for measuring concentration of a paramagnetic gas |
| 06/08/2011 | EP2330416A1 Method for verifying an electrochemical substance in a gas sample |
| 06/08/2011 | EP2330413A1 Method for quality assurance of a biosensor test strip |
| 06/08/2011 | EP2330410A2 Nitrogen-oxide gas sensor |
| 06/08/2011 | EP2330393A1 In-line Fuel Properties Measurement Unit |
| 06/08/2011 | EP2330347A1 Method for determining the carbon dioxide emitted as a result of the combustion of fuel gas |
| 06/08/2011 | EP2330220A1 Method for quantification or detection of dna |
| 06/08/2011 | EP2330219A2 Method for drug discovery, disease treatment and diagnosis using metabolomics |
| 06/08/2011 | EP2330208A1 Nanoparticles comprising RNA ligands |
| 06/08/2011 | EP2330196A2 Method for isolation of soluble polypeptides |
| 06/08/2011 | EP2330195A2 Method for isolation of soluble polypeptides |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 06/08/2011 | EP2330131A1 Antibodies against HER2 truncated variant CTF-611 |
| 06/08/2011 | EP2330128A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard |
| 06/08/2011 | EP2330121A2 Binding moieties based on Shark IgNAR domains |
| 06/08/2011 | EP2330120A2 Binding moieties based on Shark IgNAR domains |
| 06/08/2011 | EP2330118A1 Gene conferring resistance to Phytophthora infestans (late-blight) in solanaceae |
| 06/08/2011 | EP2330116A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2330115A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2329850A2 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 06/08/2011 | EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2329722A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same |
| 06/08/2011 | EP2329278A1 A single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples |
| 06/08/2011 | EP2329276A2 Centrifugal-based microfluid apparatus, method of fabricationg the same, and method of testing samples using the microfluidic apparatus |
| 06/08/2011 | EP2329275A2 Synaptic vesicle cycling assays and systems |
| 06/08/2011 | EP2329274A2 Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases |
| 06/08/2011 | EP2329273A1 Stable cell clone expressing a prion |
| 06/08/2011 | EP2329272A2 Method for detecting membrane protein internalization |
| 06/08/2011 | EP2329271A1 Methods to identify modulators |
| 06/08/2011 | EP2329270A1 Methods for screening and arraying microrganisms such as viruses using subtractive contact printing background |
| 06/08/2011 | EP2329269A1 Magnetic-label sensor and cartridge |